NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Th
Go back to NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Th| (NASDAQ: ELAB) | Delayed: 4.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.78 | 52 Week High | $ | |||
| Open | $4.78 | 52 Week Low | $ | |||
| Day High | $4.78 | P/E | N/A | |||
| Day Low | $4.78 | EPS | $ | |||
| Volume | 1,318 | |||||
